Related Experiment Video
Updated: Feb 25, 2026
16:40
A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation
Published on: February 28, 2012
26.9K
Inappropriate Implantable Cardioverter-Defibrillator Therapy
Sivakumar Ardhanari1, Ashok J Shah, Nitesh Gadeela
1Arrhythmia Services, Thoracic and Cardiovascular Institute, Sparrow Health System, Michigan State University, Lansing, MI 48910, USA.
Cardiac Electrophysiology Clinics
|August 4, 2017
Summary
Preventing inappropriate implantable cardioverter-defibrillator (ICD) therapies remains a challenge, primarily due to atrial arrhythmias. Personalized programming is key to managing these events and improving patient quality of life.
Area of Science:
- Cardiology
- Biomedical Engineering
Background:
- Implantable cardioverter-defibrillators (ICDs) have advanced, but inappropriate therapy delivery remains a significant issue for recipients.
- Atrial arrhythmias are identified as the primary cause of inappropriate ICD therapies, yet effective prevention strategies are lacking.
Purpose of the Study:
- To review the challenges in preventing inappropriate implantable cardioverter-defibrillator (ICD) therapies.
- To discuss the role of atrial arrhythmias and tachycardia detection discriminators in inappropriate therapies.
- To highlight the importance of personalized programming for ICD recipients.
Main Methods:
- Literature review of current implantable cardioverter-defibrillator (ICD) therapy guidelines and research.
- Analysis of the causes and consequences of inappropriate ICD therapies.
- Discussion of available programming options and patient-specific considerations.
Main Results:
- Atrial arrhythmias are the leading cause of inappropriate ICD therapies, posing a challenge for physicians.
- Current tachycardia detection discriminators are helpful but no single combination is ideal for all patients.
- Personalized programming based on individual patient characteristics is the most viable approach to ameliorate, though not eliminate, inappropriate therapies.
Conclusions:
- Effective prevention of inappropriate implantable cardioverter-defibrillator (ICD) therapies requires a deep understanding of patient-specific factors.
- While a universal algorithm may not be feasible, optimizing ICD programming can significantly improve patient outcomes and quality of life.
Related Concept Videos
01:29Cardiomyopathy V: Interprofessional Care
520
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
520
01:22Heart Failure VI: Adjunct Therapies
442
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
442
01:30Cardiomyopathy II: Dilated Cardiomyopathy
649
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
649
01:25ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
697
Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
697
01:23Cardiopulmonary Resuscitation III: AED Use
855
Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
855
01:25Dysrhythmias VI: Management of Dysrhythmias
544
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
544